< Back to News

DelMar Pharmaceuticals Receives $500,000 Loan from the National Brain Tumor Society and National Foundation for Cancer Research to Support VAL-083’s Participation in a Pivotal Study for Glioblastoma Sponsored by the Global Coalition for Adaptive Research

JUNE 24, 2020  |  PRNEWSWIRE
https://www.prnewswire.com/news-releases/delmar-pharmaceuticals-receives-500-000-loan-from-the-national-brain-tumor-society-and-national-foundation-for-cancer-research-to-support-val-083s-participation-in-a-pivotal-study-for-glioblastoma-sponsored-by-the-global-coaliti-301082598.html